Suppr超能文献

心血管和脑血管疾病中的miR-125家族

MiR-125 Family in Cardiovascular and Cerebrovascular Diseases.

作者信息

Wang Yang, Tan Jing, Wang Lu, Pei Gaiqin, Cheng Hongxin, Zhang Qing, Wang Shiqi, He Chengqi, Fu Chenying, Wei Quan

机构信息

Department of Rehabilitation Medicine Center, West China Hospital, Sichuan University, Chengdu, China.

Key Laboratory of Rehabilitation Medicine in Sichuan Province, Chengdu, China.

出版信息

Front Cell Dev Biol. 2021 Dec 2;9:799049. doi: 10.3389/fcell.2021.799049. eCollection 2021.

Abstract

Cardiovascular and cerebrovascular diseases are a serious threaten to the health of modern people. Understanding the mechanism of occurrence and development of cardiovascular and cerebrovascular diseases, as well as reasonable prevention and treatment of them, is a huge challenge that we are currently facing. The miR-125 family consists of hsa-miR-125a, hsa-miR-125b-1 and hsa-miR-125b-2. It is a kind of miRNA family that is highly conserved among different species. A large amount of literature shows that the lack of miR-125 can cause abnormal development of the cardiovascular system in the embryonic period. At the same time, the miR-125 family participates in the occurrence and development of a variety of cardiovascular and cerebrovascular diseases, including myocardial ischemia, atherosclerosis, ischemia-reperfusion injury, ischemic stroke, and heart failure directly or indirectly. In this article, we summarized the role of the miR-125 family in the development and maturation of cardiovascular system, the occurrence and development of cardiovascular and cerebrovascular diseases, and its important value in the current fiery stem cell therapy. In addition, we presented this in the form of table and diagrams. We also discussed the difficulties and challenges faced by the miR-125 family in clinical applications.

摘要

心脑血管疾病严重威胁着现代人的健康。了解心脑血管疾病的发生发展机制以及对其进行合理防治,是我们当前面临的巨大挑战。miR-125家族由hsa-miR-125a、hsa-miR-125b-1和hsa-miR-125b-2组成。它是一种在不同物种间高度保守的miRNA家族。大量文献表明,miR-125缺失可导致胚胎期心血管系统发育异常。同时,miR-125家族直接或间接参与多种心脑血管疾病的发生发展,包括心肌缺血、动脉粥样硬化、缺血再灌注损伤、缺血性中风和心力衰竭。在本文中,我们总结了miR-125家族在心血管系统发育成熟、心脑血管疾病发生发展以及在当前热门的干细胞治疗中的重要价值。此外,我们以表格和图表的形式呈现了这些内容。我们还讨论了miR-125家族在临床应用中面临的困难和挑战。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ebce/8674784/197efa677c78/fcell-09-799049-g001.jpg

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验